CANADA LIFE ASSURANCE Co - LA JOLLA PHARMACEUTICAL CO ownership

Quarter-by-quarter ownership
CANADA LIFE ASSURANCE Co ownership history of LA JOLLA PHARMACEUTICAL CO
ValueSharesWeighting
Q1 2019$17,000
-29.2%
2,6540.0%0.00%
Q4 2018$24,000
-54.7%
2,6540.0%0.00%
Q3 2018$53,000
-31.2%
2,6540.0%0.00%
Q2 2018$77,000
-2.5%
2,6540.0%0.00%
Q1 2018$79,000
-7.1%
2,6540.0%0.00%
Q4 2017$85,000
-6.6%
2,6540.0%0.00%
Q3 2017$91,000
+15.2%
2,6540.0%0.00%
Q2 2017$79,0000.0%2,6540.0%0.00%
Q1 2017$79,000
+68.1%
2,6540.0%0.00%
Q4 2016$47,000
-62.7%
2,654
-50.0%
0.00%
Q3 2016$126,000
+200.0%
5,308
+100.0%
0.00%
Q2 2016$42,000
-23.6%
2,6540.0%0.00%
Q1 2016$55,000
-23.6%
2,6540.0%0.00%
Q4 2015$72,0002,6540.00%
Other shareholders
LA JOLLA PHARMACEUTICAL CO shareholders Q3 2023
NameSharesValueWeighting ↓
TANG KEVIN C 240,000$1,018,00094.79%
TANG CAPITAL MANAGEMENT LLC 9,405,490$39,879,00011.22%
RTW INVESTMENTS, LP 2,327,903$9,870,0000.15%
Boxer Capital, LLC 890,700$3,777,0000.13%
FIRST MIDWEST BANK TRUST DIVISION 89,341$379,0000.05%
WealthTrust Axiom LLC 30,400$128,0000.04%
PREMIER ASSET MANAGEMENT LLC 51,305$217,0000.04%
OCCUDO QUANTITATIVE STRATEGIES LP 18,113$77,0000.02%
HOLLENCREST CAPITAL MANAGEMENT 39,000$165,0000.02%
Inscription Capital, LLC 10,000$42,0000.01%
View complete list of LA JOLLA PHARMACEUTICAL CO shareholders